Archives
ASA: Deep Learning Model Can Improve Pain Assessment
Model performed with accuracy of 88 percent for Critical Care Pain Observation Tool, 66 percent for visual analog scale
ACG: Digital Risk Assessment Tool Can ID Risk for Cancer Susceptibility Syndromes
15.6 percent of those who underwent genetic testing had pathogenic/likely pathogenic variants
ACG: Prophylactic Low-Dose Aspirin in Pregnancy Does Not Increase IBD Activity
Findings seen among pregnant patients with inflammatory bowel disease
ESMO: Pembrolizumab + Chemo, Trastuzumab Beneficial in Gastroesophageal Cancer
Improvement seen in progression-free survival with add-on pembrolizumab in gastroesophageal junction adenocarcinoma
ACG: Intestinal Ultrasound Monitoring Cuts Time to Treatment Change in IBD
Patients receiving intestinal ultrasound monitoring also achieved clinical remission earlier
Tapinarof Cream Safe, Effective for Plaque Psoriasis in Intertriginous Areas
12-week benefits include high rates of skin clearance, meaningful itch relief
ACG: Combined Oral Contraceptives Increase Risk for Irritable Bowel Syndrome
Findings seen for overall risk as well as for predominant constipation, diarrhea, and mixed bowel subtypes
ACG: Noninvasive Multitarget Stool RNA Test Has High Sensitivity for CRC
mt-sRNA has sensitivity of 94 percent for detecting colorectal cancer, 46 percent for advanced adenomas
Sotorasib + Panitumumab Beneficial for Chemorefractory Metastatic CRC
Reduced hazard ratio seen for disease progression or death with sotorasib-panitumumab versus standard care
Survival Improved With Everolimus in High-Risk Clear Cell Renal Cancer
Findings seen in clear cell renal cell carcinoma patients at very high disease risk after nephrectomy from EVEREST trial
